Scarica l'app Stockscreener
1.98
1.54%
0.03
Dopo l'orario di chiusura:
1.95
-0.03
-1.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché IBIO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.95
Aprire:
$1.87
Volume 24 ore:
319.19K
Relative Volume:
0.19
Capitalizzazione di mercato:
$68.40M
Reddito:
$300.00K
Utile/perdita netta:
$-24.74M
Rapporto P/E:
-1.9682
EPS:
-1.006
Flusso di cassa netto:
$-19.19M
1 W Prestazione:
+13.79%
1M Prestazione:
-26.39%
6M Prestazione:
+137.44%
1 anno Prestazione:
-51.94%
Intervallo 1D:
$1.87
$2.01
Intervallo di 1 settimana:
$1.69
$2.025
Portata 52W:
$0.5562
$3.95
iBio Inc Stock (IBIO) Company Profile
Nome
iBio Inc
Settore
Industria
Telefono
302-355-0650
Indirizzo
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
1.98 | 68.40M | 300.00K | -24.74M | -19.19M | -1.006 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Iniziato | Oppenheimer | Outperform |
| 2025-10-17 | Iniziato | Leerink Partners | Outperform |
| 2024-05-28 | Iniziato | Chardan Capital Markets | Buy |
| 2021-11-29 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-01-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-06-26 | Iniziato | Alliance Global Partners | Buy |
Mostra tutto
iBio Inc Borsa (IBIO) Ultime notizie
Aug Selloffs: Will iBio Inc benefit from green energy policiesInsider Selling & Real-Time Buy Zone Alerts - baoquankhu1.vn
Top iBio (IBIO) Competitors 2026 - MarketBeat
FRA:0JV0 PB Ratio: 1.01 — 33% Below Median - GuruFocus
iBio Inc. (0JV0.SG) cash flow - Yahoo Finance UK
IBIO Stock Price, Quote & Chart | IBIO INC (NASDAQ:IBIO) - ChartMill
IBIO Should I Buy - Intellectia AI
Can iBio Inc stock double in the next yearQuarterly Performance Summary & Entry and Exit Point Strategies - baoquankhu1.vn
Insider List - GuruFocus
Insider Buying: Marc Banjak Acquires Additional Shares of iBio I - GuruFocus
iBio chief legal officer Banjak buys shares worth $23,055 By Investing.com - Investing.com South Africa
iBio chief legal officer Banjak buys shares worth $23,055 - Investing.com
Insider Banjak Marc buys 13,934 iBio (IBIO) shares in open market - Stock Titan
Leerink reiterates Outperform on iBio stock amid competitor data By Investing.com - Investing.com South Africa
Leerink reiterates Outperform on iBio stock amid competitor data - Investing.com
IBIO PB Ratio: 0.91 — 41% Below Median - GuruFocus
IBIO Plummets Nearly 21%: A Biotech Ticker Stumbles in the Face of Technical Breakdown - Bitget
These stocks that are showing activity before the opening bell on Thursday. - ChartMill
Panic Selling: Is iBio Inc impacted by rising ratesWeekly Stock Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Insider Buying: Felipe Duran Acquires Shares of iBio Inc (IBIO) - GuruFocus
iBio CFO Duran acquired $50k in shares on March 19 - Investing.com India
INB.bio Launches Rebuilt Ai-Powered Affiliate Crm Platform - MarketScreener
Martin Brenner Purchases 12,336 Shares of iBio (NASDAQ:IBIO) Stock - MarketBeat
iBio (NASDAQ:IBIO) CFO Felipe Duran Acquires 24,835 Shares - MarketBeat
iBio director Brenner buys $24918 in company stock By Investing.com - Investing.com Australia
iBio director Brenner buys $24918 in company stock - investing.com
iBio CFO Duran acquired $50k in shares on March 19 By Investing.com - Investing.com Australia
IBIO | iBio, Inc. Common Stock Insider Trading - Quiver Quantitative
CFO adds 24,835 iBio (NYSE: IBIO) shares in open-market purchase - Stock Titan
iBio (IBIO) director makes open-market purchase of 12,336 shares - Stock Titan
Aug Action: Is iBio Inc a speculative investmentTrade Analysis Report & Weekly High Return Forecasts - baoquankhu1.vn
Ibio (IBIO) Receives a Buy from LifeSci Capital - The Globe and Mail
History Review: Can iBio Inc stock double in the next yearTake Profit & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
iBio (NASDAQ:IBIO) Cut to Sell at Wall Street Zen - MarketBeat
Aug Movers: Is iBio Inc impacted by rising rates2026 Earnings Surprises & Weekly Top Stock Performers List - baoquankhu1.vn
iBio Touts Bispecific Antibody Strategy for PH-HFpEF, Eyes Development Candidate in Q3 - MarketBeat
IBIO Technical Analysis | Trend, Signals & Chart Patterns | IBIO INC (NASDAQ:IBIO) - ChartMill
Chardan Capital Maintains IBio Inc(IBIO.US) With Buy Rating, Maintains Target Price $5 - 富途牛牛
IBIO: Analyst Keay Nakae Reaffirms 'Buy' Rating with $5.00 Price Target | IBIO Stock News - GuruFocus
Aug Opening: How do insiders feel about iBio IncQuarterly Trade Report & Low Drawdown Trading Strategies - baoquankhu1.vn
Jones Trading reiterates iBio stock rating on pulmonary hypertension expansion By Investing.com - Investing.com South Africa
Jones Trading reiterates iBio stock rating on pulmonary hypertension expansion - Investing.com India
VIX Spike: Is IBIO in a long term uptrend2026 PreEarnings & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
iBio (NASDAQ:IBIO) Given Buy Rating at Chardan Capital - MarketBeat
iBio (IBIO) to Discuss Pipeline Expansion in Upcoming Conference Call - GuruFocus
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - The Manila Times
Stop Loss: How sensitive is iBio Inc to inflationWeekly Gains Report & Real-Time Chart Pattern Alerts - baoquankhu1.vn
iBio to Provide an Update on Cardiopulmonary Program - GlobeNewswire
iBio reports fat reduction in primate obesity study By Investing.com - Investing.com Nigeria
Ibio SEC Filings - Stock Titan
iBio, Inc. (NASDAQ:IBIO) Given Consensus Rating of "Buy" by Analysts - MarketBeat
iBio Inc Azioni (IBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):